0001493152-26-039439.txt : 20260820 0001493152-26-039439.hdr.sgml : 20260820 20260820141406 ACCESSION NUMBER: 0001493152-26-039439 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260820 DATE AS OF CHANGE: 20260820 EFFECTIVENESS DATE: 20260820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensysce Biosciences, Inc. CENTRAL INDEX KEY: 0001716947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 822755287 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-594907 FILM NUMBER: 261299098 BUSINESS ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 263-4196 MAIL ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Leisure Acquisition Corp. DATE OF NAME CHANGE: 20170913 D 1 primary_doc.xml X0708 D LIVE 0001716947 Ensysce Biosciences, Inc. 7946 IVANHOE AVE, SUITE 201 LA JOLLA CA CALIFORNIA 92037 (858) 263-4196 DELAWARE None Leisure Acquisition Corp. Corporation true D Lynn Kirkpatrick 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Director Bob Gower 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director William Chang 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Steve Martin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Adam Levin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director David Humphrey 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer James Morrison 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Director Other Health Care Decline to Disclose 06b false 2026-08-05 false true true true 0 UBS Securities LLC 000007654 None None 11 Madison Avenue New York NY NEW YORK 10010 All States true Cantor Fitzgerald & Co. 000000134 None None 110 East 59th Street, 4th Floor New York NY NEW YORK 10010 All States true 77200000 77200000 0 Of Total Amount Sold, $38.6 million is subject to certain contingencies false 44 1289946 200000 0 false Ensysce Biosciences, Inc. /s/ Lynn Kirkpatrick Dr. Lynn Kirkpatrick CEO 2026-08-20